The Aspirin Dilemma in an Older Women with Asthma and Coronary Artery Disease : A Case Report of suspected Aspirin Exacerbated Respiratory Disease
Introduction: Aspirin-exacerbated respiratory disease (AERD, also called aspirin-induced asthma or Samter's triad) is an asthma phenotype in which aspirin and other COX-1 inhibitors can trigger bronchospasm, usually alongside chronic rhinosinusitis with nasal polyps. It creates a real prescribing problem when the patient also has coronary artery disease, because the drug that protects the heart may be the one that provokes the airway. Choosing a safe antiplatelet drug, while keeping the asthma regimen safe too, calls for close cooperation between the treating team and the clinical pharmacist. Main symptoms and clinical findings: A 71-year-old woman with long-standing asthma, a previous episode of pulmonary infiltrates with eosinophilia (PIE), recurrent rhinitis and coronary artery disease came in with two to three days of worsening wheeze, chest tightness and increased sputum. She had bilateral wheeze but stable vital signs, with an oxygen saturation of 98% on room air. High-sensitivity troponin I was normal (1.9 pg/mL), and her renal and liver function were normal. Diagnoses, interventions and outcomes: The working diagnosis was an acute exacerbation of asthma with possible AERD. She was treated with nebulised levosalbutamol–ipratropium, formoterol–budesonide, tiotropium, intravenous hydrocortisone, etofylline/theophylline, montelukast–levocetirizine and antibiotics. Sinus CT showed no polyps and no aspirin reaction was documented, so the AERD label stayed presumptive. After cardiology review, aspirin was stopped on Day 4, while clopidogrel and rosuvastatin were continued. Her wheeze, breathlessness and sputum improved, and she went home on Day 6. Conclusion: When an older patient with asthma and coronary disease may have AERD, the aspirin question is a medicines problem as much as a diagnostic one. Here, a presumptive label made without nasal polyps or a documented aspirin reaction led to aspirin being stopped and clopidogrel continued. The case argues for a structured aspirin and NSAID history at admission, so that antiplatelet decisions rest on a recorded reaction and not on suspicion.
Authors
- Mirdula Mary E
- Mourishnawin R K
- Marin Aravindh A D
- Dr Ramanaprasanth G
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-16
- DOI
- https://doi.org/10.5281/zenodo.24270997
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00